drugset / Trial / NCT01746901
A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers
RandomizedCrossoverDouble-blindOther
Summary
The main purpose of this study is to determine if oxycodone and naltrexone combination capsules (ALO-02) have the potential to be abused.
Timeline
- Start
- 2013-02
- Primary completion
- 2013-08-09
- Completion
- 2013-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 4.8 mg | Oral |
| Subject | Naltrexone | Small molecule | 7.2 mg | Oral |
| Comparator | Oxycodone | Other / unclassified | 40 mg | Oral |
| Comparator | Oxycodone | Other / unclassified | 60 mg | Oral |
Indications
No indication recorded.